Tradestie Institutional Equity Comparison Engine

ASMB vs VIVS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ASMB Overall Edge

ASMB Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Assembly Biosciences, Inc (ASMB) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ASMB trades at N/M Forward P/E with -31.8% operating margin (-72.6% YoY revenue) versus VIVS at N/M Forward P/E and -10117.0% operating margin (-51.4% YoY). In options structure, ASMB sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ASMB
ASMB N/M vs VIVS N/M Fwd P/E
Growth & Margin Winner ASMB
Op Margin -31.8% vs -10117.0% ยท YoY -72.6% vs -51.4%
Momentum & Technical Winner ASMB
1Y -37.3% vs -87.0% ยท 52W Pos 16% vs 5%
Options & Structure Winner ASMB
UNCLASSIFIED (100th %ile IV) vs BREAKDOWN (N/A IV)
ASMB NASDAQ
Assembly Biosciences, Inc
Pharmaceutical Preparations
$22.50
+0.49% 1D
Market Cap $464.6M
1M Return +9.97%
1Y Return -37.31%
Forward P/E N/M
Unified AI Score
31.0 / 100 SELL
Tech 3.0 Fund 37.0 Flow 50.0 Mom 40.0
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
1M Return +64.69%
1Y Return -86.99%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 5.0 Fund 38.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ASMB -37.31% VIVS -86.99% Spread: +49.68 pp (ASMB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ASMB TTM Op. Margin: -31.8% VIVS TTM Op. Margin: -10117.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ASMB vs VIVS. Trailing 12-month operating profitability (ASMB -31.8% vs VIVS -10117.0%) and valuation multiples (ASMB N/M vs VIVS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ASMB (6) vs VIVS (3)
Institutional Metric ASMB VIVS Criterion Row Winner
Market Capitalization Scale $464.6M $2.4M Larger Scale ASMB
Trailing P/E Ratio Valuation 30.2x N/M Lower Multiple ASMB
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -72.6% -51.4% Higher Growth VIVS
Operating Margin (TTM) Profitability -31.8% -10117.0% Higher Margin ASMB
Net Profit Margin Profitability -16.6% 0.0% Higher Margin VIVS
Return on Equity (ROE) Capital Efficiency -4.6% -343.1% Higher ROE ASMB
52-Week Range Position Momentum 16% ($19โ€“$40) 5% ($0โ€“$3) Stronger Trend ASMB
Beta / 30D Volatility Risk Regime 0.99ฮฒ ยท 57% Vol 0.83ฮฒ ยท 480% Vol Lower Realized Risk ASMB
Unified Institutional Score Composite Signal 31.0 / 100 (SELL) 36.8 / 100 (SELL) Higher Composite VIVS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ASMB vs VIVS Buy Guide
ASMB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ASMB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VIVS BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VIVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ASMB nor VIVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.